The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: Longitudinal quasi-experimental design

Amanj Baker, Li Chia Chen*, Rachel A. Elliott, Brian Godman

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Citations (Scopus)

Fingerprint

Dive into the research topics of 'The impact of the 'Better Care Better Value' prescribing policy on the utilisation of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for treating hypertension in the UK primary care setting: Longitudinal quasi-experimental design'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences